🔗 Permalink

Inventor profile of:

Gan Wang

City:

Wallingford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2011-12-01

Top Assignees for applications by Gan Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Gan:

BRISTOL-MYERS SQUIBB COMPANY 9 Princeton, NJ United States
Bayer Pharmaceuticals Corporation 7 West Haven, CT United States
BAYER HEALTHCARE LLC 5 Tarrytown, NY United States
Bayer Intellectual Property GmbH 2 Monheim, Germany
Bayer Schering Pharma Aktiengesellschaft 1 Berlin, Germany
BAYER HEALTHCARE AG 1 Leverkusen, Germany
Bayer Phamaceuticals Corporation 1 West Haven, CT United States
Bayer Pharmaceuticals Corporation 1 West Haven, United States

Recent patent applications by Wang Gan

Gan Wang from Wallingford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-12-01

US20110294776A1

Chemistry; metallurgy

Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases

#2 | 2011-11-24

US20110286961A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#3 | 2011-11-10

US20110274648A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#4 | 2011-06-09

US20110136809A1

Chemistry; metallurgy

Substituted pyrazolyl urea derivatives useful in the treatment of cancer

#5 | 2011-03-31

US20110077280A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#6 | 2011-03-03

US20110053928A1

Chemistry; metallurgy

PYRIMIDOTHIENOINDAZOLES

#7 | 2010-04-01

US20100081812A1

Chemistry; metallurgy

Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders

#8 | 2009-10-29

US20090270468A1

Chemistry; metallurgy

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

#9 | 2009-10-08

US20090253762A1

Chemistry; metallurgy

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

#10 | 2009-09-17

US20090233925A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#11 | 2009-08-27

US20090215780A1

Chemistry; metallurgy

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

#12 | 2009-08-13

US20090202483A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#13 | 2009-08-13

US20090202478A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#14 | 2009-08-06

US20090197795A1

Chemistry; metallurgy

PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY

#15 | 2009-07-23

US20090186887A1

Chemistry; metallurgy

NOVEL PYRIMIDOTHIENOINDAZOLES

#16 | 2009-03-12

US20090068140A1

Human necessities

Hepatitis C virus inhibitors

#17 | 2008-12-18

US20080311075A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#18 | 2008-12-04

US20080299075A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#19 | 2008-02-28

US20080050336A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#20 | 2007-12-27

US20070299066A1

Chemistry; metallurgy

Pyrimidothienoindazoles

#21 | 2006-08-31

US20060194859A1

Chemistry; metallurgy

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

#22 | 2006-08-15

US10839833

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

#23 | 2005-11-17

US20050256167A1

Chemistry; metallurgy

Preparation and use of imidazole derivatives for treatment of obesity

#24 | 2005-11-01

US10255049

Preparation and use of imidazole derivatives for treatment of obesity

#25 | 2005-02-17

US20050038031A1

Chemistry; metallurgy

Bicyclic urea derivatives useful in the treatment of cancer and other disorders

#26 | 2005-02-10

US20050032798A1

Chemistry; metallurgy

2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders

InventorID:

3352712 ⎘